Advanced Sleep Phase Syndrome (ASPD/ASWPD)
Advanced Sleep Phase Syndrome is a circadian rhythm disorder where individuals involuntarily fall asleep in the early evening (6:00-9:00 pm) and wake in the early morning hours (2:00-5:00 am), occurring earlier than desired or socially conventional times, with otherwise normal sleep quality when following their preferred schedule. 1, 2
Core Clinical Features
Sleep Timing Characteristics:
- Sleep onset occurs as early as 6:00 pm to 9:00 pm, even when patients actively attempt to delay sleep 1, 2
- Wake times occur between 2:00 am to 5:00 am 1, 2
- The major sleep episode is involuntarily advanced by several hours relative to conventional timing 2
Associated Symptoms:
- Excessive evening sleepiness that interferes with social and occupational functioning 2
- Early morning awakening (sleep maintenance insomnia) 1, 2
- When permitted to follow their preferred early schedule, sleep quality, architecture, and duration are completely normal 1, 2
Critical Distinction: Not all early risers have ASPD—many older adults are simply "morning types" or "larks" who adapt without functional impairment or distress 1
Underlying Pathophysiology
Circadian Misalignment:
- The endogenous circadian clock is phase-advanced, causing biological sleep drive to peak in early evening rather than conventional bedtime 2
- Core body temperature nadir occurs earlier than normal (around 1:38 am in documented cases) 2, 3
- Melatonin secretion onset (DLMO) occurs several hours earlier than typical 2, 3
- The circadian period may be shortened to less than 24 hours 1
Contributing Factors in Older Adults:
- Decreased evening light exposure, often exacerbated by cataracts and other ophthalmologic conditions 1, 2
- Reduced homeostatic sleep drive with aging 2
- Weakened responses to circadian entrainment agents like light and physical activity 1
Genetic Factors:
- Familial forms exist with autosomal dominant inheritance patterns 1
- Mutations identified in circadian clock genes including hPer2, CK1 delta, and CSNK1D 1, 4
Epidemiology
- Prevalence in middle-to-older aged adults: 1-7% 1, 2
- Much less common in younger adults, with only sporadic non-age-related cases reported 1, 2
Diagnostic Approach
Required Components:
- Clinical history documenting sleep-wake times earlier than desired with functional impairment 2
- Sleep diary and/or actigraphy for at least 7 days demonstrating the characteristic advanced pattern 1, 2
- Exclusion of other conditions: other sleep disorders (sleep apnea, restless legs syndrome, REM sleep behavior disorder), psychiatric conditions (depression, anxiety), medications, and substance use 1, 2
Confirmatory Testing (Optional but Helpful):
- Dim Light Melatonin Onset (DLMO) shows earlier onset of melatonin secretion 2, 3
- Core body temperature minimum occurs earlier than normal 1, 2
- Polysomnography (not routinely indicated) would show shortened initial sleep latency at conventional bedtimes 2
Critical Diagnostic Pitfalls:
- Assess for comorbid sleep disorders common in older adults: restless legs syndrome and REM sleep behavior disorder 2
- Screen for psychiatric comorbidities, particularly depression and anxiety, which frequently coexist and can mimic ASPD 1, 2
Treatment Strategies
Evening Bright Light Therapy (Primary Treatment):
- Administer bright light (2500-10,000 lux) for 1-2 hours in the evening between 7:00-9:00 pm 1
- This timing falls within the phase delay portion of the light phase response curve (PRC) 1
- Can normalize or delay circadian rhythms and may improve sleep efficiency and total sleep time 1
- Caveat: Lower intensity light may not effectively delay sleep phase 1
- Age consideration: Older adults show reduced response to blue light compared to younger individuals 1
Behavioral Interventions:
- Good sleep hygiene practices combined with methods to delay sleep and wake times 1
- Increase evening light exposure and physical activity 1
- Address ophthalmologic conditions (e.g., cataracts) that reduce evening light exposure 1, 2
Chronotherapy (Limited Practicality):
- Sleep times are progressively advanced every 2 days until desired schedule is achieved 1
- Major limitations: Requires rigorous compliance, lengthy treatment duration, and close follow-up 1
Treatment Outcomes: